FMS

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About Fresenius Medical Care AG & Co. KGaA

CEO
Rice Powell
Employees
125364
Headquarters

Else-Kroener-Strasse 1
Bad Homburg Vor Der Hohe, Hessen 61352
Phone: 4961726090
https://www.freseniusmedicalcare.com/

News

Opioid Kappa Receptor Agonists Market to Witness Significant Growth by 2034, Asserts DelveInsight | Fresenius Medical Care, Cara Therapeutics, Toray Industries, Torii Pharma
Apr 04, 2024 12:35pm

The Opioid Kappa Receptor Agonists market size is anticipated to grow in the upcoming years, largely driven by heightened R&D endeavors across the 7MM. Furthermore, the competitive landscape remains relatively sparse, indicating that the regulatory approval process is likely to


Source:OpenPR
What Makes Fresenius Medical Care AG (FMS) a Potential Investment?
Mar 25, 2024 14:59pm

Ariel Investments, an investment management company, released its “Ariel Global Fund” fourth-quarter 2023 investor letter. A copy of the same can be downloaded here. In the fourth quarter, the Ariel Global fund returned +8.40% gross of fees (+8.18% net of fees), compared to the MSCI ACWI Index’s +11.03%, and the MSCI ACWI Value Index’s +9.17% gains. […]


Source:Insider Monkey
Fresenius Medical Care publishes 2023 joint Annual Report and Sustainability Report: Shaping the Future of Kidney Care | FMS Stock News
Mar 22, 2024 12:00pm

Fresenius Medical Care (FME) delivers on commitments during a year of fundamental transformation, making progress towards sustainability goals in key areas such as patient satisfaction, diversity in management, and climate target roadmap.


Source:Stock Titan
EQS-DD: Fresenius Medical Care AG: Franklin W. Maddux, Acquisition of shares under the Fresenius Medical Care Management Board Long Term Incentive Plan 2020 (Allocation 2021)
Mar 19, 2024 13:06pm

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 19.03.2024 / 14:05 CET/CEST The issuer is solely responsible for the content of this announcement. 1. Details of the person discharging managerial responsibilities / person closely associated Jetzt den vollständigen Artikel lesen


Source:Wallstreet:Online
EQS-DD: Fresenius Medical Care AG: Dr. Katarzyna Mazur-Hofsäß, Acquisition of shares under the Fresenius Medical Care Management Board Long Term Incentive Plan 2020 (Allocation 2021)
Mar 19, 2024 13:03pm

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 19.03.2024 / 14:02 CET/CEST The issuer is solely responsible for the content of this announcement. 1. Details of the person discharging managerial responsibilities / person closely associated Jetzt den vollständigen Artikel lesen


Source:Wallstreet:Online
EQS-DD: Fresenius Medical Care AG: Helen Pring Giza, Acquisition of shares under the Fresenius Medical Care Management Board Long Term Incentive Plan 2020 (Allocation 2021)
Mar 19, 2024 13:01pm

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 19.03.2024 / 14:00 CET/CEST The issuer is solely responsible for the content of this announcement. 1. Details of the person discharging managerial responsibilities / person closely associated Jetzt den vollständigen Artikel lesen


Source:Wallstreet:Online
Fresenius Medical Care launches "Augmented Reality" for training on Kidney Replacement Therapy device
Mar 19, 2024 12:00pm

For the first time, Fresenius Medical Care develops and utilizes "Augmented Reality" (AR) to train medical staff in Intensive Care Units (ICUs) The new training application for ICU staff combines digital learning elements with real-life training on the Fresenius Medical Care Continuous…


Source:PR Newswire
Why Are Dialysis Provider Stocks Trading Higher On Tuesday?
Mar 05, 2024 20:21pm

Tuesday, Novo Nordisk A/S (NYSE: NVO ) released the headline results from the kidney outcomes trial, FLOW. The trial achieved its primary endpoint by demonstrating a statistically significant and superior reduction in kidney disease progression as well as cardiovascular and kidney death of 24% for people treated with semaglutide 1.0 mg compared to placebo . Stocks of kidney dialysis-focused DaVita Inc (NYSE: DVA ), Fresenius Medical Care AG (NYSE: FMS ), and Baxter International Inc (NYSE: BAX ) shares fell sharply when Novo Nordisk stopped the … Full story available on Benzinga.com


Source:Benzinga
EQS-DD: Fresenius Medical Care AG: Craig Cordola, buy
Feb 23, 2024 15:33pm

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 23.02.2024 / 16:32 CET/CEST The issuer is solely responsible for the content of this announcement. 1. Details of the person discharging managerial responsibilities / person closely associated Jetzt den vollständigen Artikel lesen


Source:Wallstreet:Online
Fresenius Medical Care AG: Craig Cordola, buy
Feb 23, 2024 15:32pm

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 23.02.2024 / 16:32 CET/CEST The issuer is solely responsible for the content of this announcement. 1. Details of the person discharging managerial responsibilities / person closely associated a) Name Title: First name: Craig Last name(s): Cordola 2. Reason for the notification a) Position / status Position: Member of the managing body b) Initial notification 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name Fresenius Medical Care AG b) LEI 549300CP8NY40UP89Q40 4. Details of the transaction(s) a) Description of the financial instrument, type of instrument, identification code Type: Financial instrument linked to a share or a debt instrument ISIN: US3580291066 b) Nature of the transaction Acquisition c) Price(s) and volume(s) Price(s) Volume(s) 19.345 USD 13,541.50 USD 19.345 USD 1,934.


Source:EQS News